Question 1

Has Arya Amini, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,079,466 in general payments to Arya Amini, MD across 212 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Arya Amini, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Arya Amini, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Reflexion Medical, Inc.	22	$407,647
Siemens Medical Solutions USA, Inc.	7	$266,602
AstraZeneca	114	$185,207
Regeneron	17	$137,174
Takeda Pharmaceuticals U.S.A., Inc.	39	$57,346
Sanofi	5	$12,240
Astrazeneca UK Limited	4	$10,275
Amgen	2	$2,892
Brainlab, Inc.	2	$83

Arya Amini, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other radiation oncology in Duarte